Language selection

Search

Patent 2802956 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2802956
(54) English Title: VULCANIZATION COMPOSITION HAVING REDUCED ALLERGENIC POTENTIAL
(54) French Title: COMPOSITION DE VULCANISATION AU POTENTIEL ALLERGENE REDUIT
Status: Granted
Bibliographic Data
(51) International Patent Classification (IPC):
  • C08L 11/02 (2006.01)
  • B29C 35/00 (2006.01)
  • B29D 22/00 (2006.01)
  • C08C 19/30 (2006.01)
  • C08J 3/24 (2006.01)
  • C08K 3/06 (2006.01)
  • C08K 3/22 (2006.01)
  • C08K 5/38 (2006.01)
  • C09D 111/02 (2006.01)
  • C09D 7/12 (2006.01)
(72) Inventors :
  • CHEN, SEONG FONG (Malaysia)
  • WONG, WEI CHEONG (Malaysia)
  • LOW, CHII YIH (Malaysia)
(73) Owners :
  • ALLEGIANCE CORPORATION (United States of America)
(71) Applicants :
  • ALLEGIANCE CORPORATION (United States of America)
(74) Agent: GOWLING WLG (CANADA) LLP
(74) Associate agent:
(45) Issued: 2018-07-10
(86) PCT Filing Date: 2011-06-27
(87) Open to Public Inspection: 2011-12-29
Examination requested: 2016-04-05
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2011/042028
(87) International Publication Number: WO2011/163662
(85) National Entry: 2012-12-14

(30) Application Priority Data:
Application No. Country/Territory Date
61/358,721 United States of America 2010-06-25

Abstracts

English Abstract



The present invention generally relates to vulcanization compositions used to
vulcanize
elastomeric articles, where the vulcanization compositions have reduced
allergenic potential as
compared to elastomeric articles formed using vulcanization compositions
having non-fugitive
accelerators. The vulcanization composition comprises: a source of sulfur, a
single fugitive or
one or more dialkyl xanthogen disulfide accelerator, and a metal oxide. The
composition does
not include any additional compounds that function as accelerators for
vulcanizing elastomers or
the composition does not include any non-fugitive accelerators. The present
invention also
relates to elastomeric articles formed using the vulcanization compositions.
The invention further
relates to methods for making a reduced-allergenicity vulcanization
composition, and to methods
for using the vulcanization compositions to vulcanize elastomeric articles.


French Abstract

D'une manière générale, la présente invention concerne des compositions de vulcanisation qui sont utilisées pour vulcaniser des articles élastomères, les compositions de vulcanisation ayant un potentiel allergène réduit en comparaison avec des articles élastomères formés à l'aide de compositions de vulcanisation ayant des accélérateurs non fugitifs. La présente invention concerne également des articles élastomères formés à l'aide des compositions de vulcanisation. L'invention concerne en outre des procédés de fabrication d'une composition de vulcanisation dont le potentiel allergène est réduit, et des procédés d'utilisation des compositions de vulcanisation pour vulcaniser des articles élastomères.

Claims

Note: Claims are shown in the official language in which they were submitted.



We claim

1. A vulcanization composition comprising:
a source of sulfur,
a single fugitive dialkyl xanthogen disulfide accelerator, and
a metal oxide,
wherein the composition does not include any additional compounds that
function as
accelerators for vulcanizing elastomers.
2. A vulcanization composition comprising:
elemental sulfur,
dialkyl xanthogen disulfide as the sole fugitive accelerator, and
a metal oxide,
wherein the composition does not include any additional compounds that
function as
accelerators for vulcanizing elastomers.
3. A vulcanization composition consisting of:
elemental sulfur,
dialkyl xanthogen disulfide, and
a metal oxide.
4. The vulcanization composition of any one of claims 1-3, wherein the
vulcanization
composition exhibits reduced allergenicity as compared to conventional
vulcanization
compositions.
5. The vulcanization composition of any one of claims 1-4, wherein the
metal oxide is
selected from the group consisting of zinc oxide, magnesium oxide, lead oxide,
and combinations
thereof.
6. The vulcanization composition of claim 1, wherein the source of sulfur
is selected from the
group consisting of elemental sulfur, sulfur donors that have a low allergenic
potential, and
combinations thereof.
26
26


7. The vulcanization composition of claim 1, wherein the single fugitive
dialkyl xanthogen
disulfide accelerator is selected from the group consisting of dibutyl
xanthogen disulfide, and
diisopropyl xanthogen disulfide.
8. A method for forming a vulcanization composition comprising:
providing a source of sulfur,
providing a single dialkyl xanthogen disulfide,
providing a metal oxide, and
mixing the source of sulfur, single dialkyl xanthogen disulfide, and metal
oxide,
wherein the method for forming the vulcanization composition does not include
any
additional compounds that function as accelerators for vulcanizing elastomers.
9. A latex dispersion comprising:
polychloroprene, and
a vulcanization composition consisting of:
elemental sulfur,
diisopropyl xanthogen polysulfide, and
a metal oxide,
wherein the latex dispersion does not include any additional compounds that
function as
accelerators for vulcanizing elastomers.
10. A method for preparing a reduced-allergenicity polychloroprene
elastomeric article,
comprising:
providing the latex dispersion of claim 9,
coating a former with the latex dispersion by coagulant dipping to form a
first elastomeric
layer, and
drying and vulcanizing the first elastomeric layer.
11. The method of claim 10, further comprising:
coating the former coated with the first elastomeric layer with a second latex
dispersion to
form a second elastomeric layer,
wherein the second elastomeric layer is applied prior to drying and
vulcanizing the first
elastomeric layer.

27


12. The method of claim 11, wherein the second elastomeric layer has the
same composition
as the first elastomeric layer.
13. The method of claim 11, wherein the second elastomeric layer has a
different composition
from the first elastomeric layer.
14. The method of claim 13, wherein the second elastomeric layer is formed
from a second
latex dispersion comprising a polymer latex selected from the group consisting
of natural rubber,
polyurethane, polybutadiene, polychloroprene, nitrile rubber, block copolymers
of styrene and
butadiene, block copolymers of styrene and isoprene, and synthetic
polyisoprene.
15. A coating for an elastomeric article, comprising:
the latex dispersion of claim 9;
a second polymer latex dispersion comprising a polymer latex selected from the
group
consisting of natural rubber, polyurethane, polybutadiene, polychloroprene,
nitrile rubber, block
copolymers of styrene and butadiene, block copolymers of styrene and isoprene,
and synthetic
polyisoprene, and
water,
wherein the total solids content of the second polymer latex dispersion is
from about 3%
to about 15%.
16. The coating of claim 15, wherein the polymer latex is selected from the
group consisting
of nitrite rubber and synthetic polyisoprene.
17. An elastomeric article formed using the vulcanization composition of
any one of
claims 1-7, wherein the elastomeric article does not include any additional
compounds that
function as accelerators for vulcanizing elastomers.
18. An elastomeric article formed using the latex dispersion of claim 9,
wherein the
elastomeric article does not include any additional compounds that function as
accelerators for
vulcanizing elastomers.
19. An elastomeric article formed using the coating of claim 15 or 16,
wherein the elastomeric
article does not include any additional compounds that function as
accelerators for vulcanizing
elastomers.

28


20. The elastomeric article of any one of claims 17-19, wherein the
elastomeric article exhibits
reduced allergenicity as compared to elastomeric articles formed using
conventional accelerators.
21. The elastomeric article of any one of claims 17-19, wherein the
elastomeric article is
selected from the group consisting of gloves, probe covers, finger cots,
catheters, dental dams,
and condoms.
22. The elastomeric article of any one of claims 17-19, wherein the
elastomeric article is
powder free.
23. A vulcanization composition comprising:
a source of sulfur,
one or more dialkyl xanthogen disulfide accelerators, and
a metal oxide,
wherein the composition does not include any non-fugitive accelerators.
24. A vulcanization composition comprising:
elemental sulfur,
dialkyl xanthogen disulfide as a fugitive accelerator, and
a metal oxide,
wherein the composition does not include any non-fugitive accelerators.
25. The vulcanization composition of claim 23 or 24, wherein the
vulcanization composition
exhibits reduced allergenicity as compared to conventional vulcanization
compositions.
26. The vulcanization composition of any one of claims 23-25, wherein the
metal oxide is
selected from the group consisting of zinc oxide, magnesium oxide, lead oxide,
and combinations
thereof.
27. The vulcanization composition of claim 23, wherein the source of sulfur
is selected from
the group consisting of elemental sulfur, sulfur donors that have a low
allergenic potential, and
combinations thereof.

29


28. The vulcanization composition of claim 23, wherein the one or more
dialkyl xanthogen
disulfide accelerator is selected from the group consisting of dibutyl
xanthogen disulfide, and
diisopropyl xanthogen disulfide.
29. A method for forming a vulcanization composition comprising:
providing a source of sulfur,
providing one or more dialkyl xanthogen disulfide,
providing a metal oxide, and
mixing the source of sulfur, one or more dialkyl xanthogen disulfide, and
metal oxide,
wherein the method for forming the vulcanization composition does not include
any non-fugitive
accelerators.
30. A latex dispersion comprising:
polychloroprene, and
a vulcanization composition consisting of:
elemental sulfur,
diisopropyl xanthogen polysulfide, and
a metal oxide,
wherein the latex dispersion does not include any non-fugitive accelerators.
31. A method for preparing a reduced-allergenicity polychloroprene
elastomeric article,
comprising:
providing the latex dispersion of claim 30,
coating a former with the latex dispersion by coagulant dipping to form a
first elastomeric
layer, and
drying and vulcanizing the first elastomeric layer.
32. The method of claim 31, further comprising:
coating the former coated with the first elastomeric layer with a second latex
dispersion to
form a second elastomeric layer,
wherein the second elastomeric layer is applied prior to drying and
vulcanizing the first
elastomeric layer.



33. The method of claim 32, wherein the second elastomeric layer has the
same composition
as the first elastomeric layer.
34. The method of claim 32, wherein the second elastomeric layer has a
different composition
from the first elastomeric layer.
35. The method of claim 34, wherein the second elastomeric layer is formed
from a second
latex dispersion comprising a polymer latex selected from the group consisting
of natural rubber,
polyurethane, polybutadiene, polychloroprene, nitrile rubber, block copolymers
of styrene and
butadiene, block copolymers of styrene and isoprene, and synthetic
polyisoprene.
36. A coating for an elastomeric article, comprising:
the latex dispersion of claim 30,
a second polymer latex dispersion comprising a polymer latex selected from the
group
consisting of natural rubber, polyurethane, polybutadiene, polychloroprene,
nitrile rubber, block
copolymers of styrene and butadiene, block copolymers of styrene and isoprene,
and synthetic
polyisoprene, and
water,
wherein the total solids content of the second polymer latex dispersion is
from about 3%
to about 15%.
37. The coating of claim 36, wherein the polymer latex is selected from the
group consisting
of nitrile rubber and synthetic polyisoprene.
38 An elastomeric article formed using the vulcanization composition of any
one of claims 23-
28, wherein the elastomeric article does not include any non-fugitive
accelerators.
39. An elastomeric article formed using the latex dispersion of claim 30,
wherein the
elastomeric article does not include any non-fugitive accelerators.
40. An elastomeric article formed using the coating of claim 36 or 37,
wherein the elastomeric
article does not include any non-fugitive accelerators.

31


41. The elastomeric article of any one of claims 38 to 40, wherein the
elastomeric article
exhibits reduced allergenicity as compared to elastomeric articles formed
using conventional
accelerators.
42. The elastomeric article of any one of claims 38 to 40, wherein the
elastomeric article is
selected from the group consisting of gloves, probe covers, finger cots,
catheters, dental dams,
and condoms.
43. The elastomeric article of any one of claims 38 to 40, wherein the
elastomeric article is
powder free.

32

Description

Note: Descriptions are shown in the official language in which they were submitted.


VULCANIZATION COMPOSITION HAVING REDUCED ALLERGENIC POTENTIAL
[0001]
Background of the Invention
1. Field of the Invention
[0002] The present invention generally relates to vulcanization
compositions
including accelerator compositions used to vulcanize elastomeric articles,
where the
vulcanization compositions have reduced allergenic potential as compared to
elastomeric articles formed using conventional vulcanization compositions. The
present
invention also relates to polychloroprene-based elastomeric articles formed
using the
vulcanization compositions. The invention also relates to methods for making a

reduced allergenicity vulcanization composition, and to methods for using the
vulcanization compositions to vulcanize elastomeric articles. According to
some
aspects the vulcanization compositions may include sulfur, the accelerator
compositions, and an activator composition. According to another aspect, the
accelerator compositions may include a fugitive vulcanization accelerator and
the
activator composition may include zinc oxide. According to further aspects,
the
elastomeric articles may include gloves, finger cots, catheters, and condoms.
2. Description of Related Art
[0003] There are two types of allergies associated with the use of
elastomeric
articles in the medical field: (a) Type I immediate hypersensitivity, IgE-
mediated
allergies; and (b) Type IV delayed hypersensitivity, cell-mediated allergies.
[0004] Type I hypersensitivity reactions are mediated by IgE
immunoglobulin, and
the effect is immediate. Generally, symptoms are evident within minutes of
exposure to
the allergen, and may include local urticaria, facial swelling, watery eyes,
rhinitis,
-1-
CA 2802956 2017-08-17

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
asthma, and in extremely rare occasions, anaphylactic shock. Type I allergies
have
been linked to the residual, extractable proteins present in natural rubber
latex products.
[0005] Various technologies are available for reducing the extractable
proteins in
latex gloves, such as water leaching, chlorination, and the use of low-protein
or
deproteinated latex. However, healthcare personnel and patients who are
allergic to
natural rubber latex proteins are advised to use synthetic gloves. Commonly-
used
synthetic materials include polyisoprene,
acrylonitrile-butadiene (nitrile),
polychloroprene (Neoprene), polyurethane, and polyvinyl chloride.
[0006] As a result of the prevalence of Type I reactions in response to
contact
with natural rubber proteins, there has been a shift towards the use of
synthetic latexes
that do not contain natural rubber latex proteins, especially for use in
making medical
devices that come into contact with the skin. Taking cost and performance into

consideration, synthetic latexes that are suitable for glove manufacture
include nitrite
latex and polyurethane latex for examination gloves, and polychloroprene latex
and
polyisoprene latex for surgical gloves. For surgical gloves, polyisoprene
latex has
typically been preferred over polychloroprene, even though it is more
expensive,
because it provides the gloves with properties that mimic those of natural
rubber,
particularly tensile strength, ultimate elongation, softness and comfortable
feel.
[0007] However, Type IV allergic reactions can be caused by natural or
synthetic
elastomeric articles. Synthetic latexes can still cause allergic reactions due
to the use
of certain chemicals that may be found in the compounded latex. Type IV
delayed
hypersensitivity reactions are cell-mediated allergic responses to specific
chemicals.
Symptoms only become apparent about 48-96 hours after contact. Chemicals that
may
induce Type IV allergic responses include vulcanization accelerators such as
thiurams,
mercaptobenzothiazoles, dithiocarbamates, diphenylguanidines, and thioureas,
which
are used in the process of preparing the elastomeric articles. The U.S. Food
and Drug
Administration (FDA) acknowledges that thiazoles, thiurams, and carbamates in
rubber
products can induce Type IV allergic reactions in humans. "Guidance for
Industry and
FDA Reviewers/Staff: Premarket Notification [510(k)] Submissions for Testing
for Skin
Sensitization to Chemicals in Natural Rubber Products," U.S. Department of
Health and
-2-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
Human Services (1999). Hence, it is important to minimize the level of
accelerators
used so that the residual accelerator in the finished elastomeric article is
very low.
[0008]
Elastomeric articles are generally manufactured using a latex dipping
process, which involves dipping molds or formers into a coagulant solution
(usually
aqueous calcium nitrate). After evaporating off the solvent, the coagulant-
coated
molds/formers are then dipped into compounded latex such that a film of
coagulated
rubber particles is deposited thereon. After gelling the latex film using
heat, the wet-
gelled latex film is leached in water and then dried and vulcanized in a hot
air oven.
During vulcanization the rubber molecules are chemically crosslinked.
[0009] Most
commonly, the crosslinking agent is sulfur. However, sulfur alone is
inefficient for forming crosslinks. Conventionally, sulfur has always been
used in
combination with vulcanization accelerators and activators.
[00010]
Vulcanization accelerators are usually organic compounds that increase
the rate and efficiency of sulfur crosslinking, while activators are compounds
that
increase the efficiency of the accelerators. Examples of accelerators used in
latex
compounding include thiurams,
dithiocarbamates, mercaptobenzthiazole,
diphenylguanidine, and thioureas. After vulcanization, depending on the amount
of the
accelerator used, some or most of the accelerators are chemically bonded to
the rubber
matrix, but some are unreacted and may remain as a residue in the finished
elastomeric
article.
[00011]
Vulcanization activators used in latex compounding are usually metal
oxides, such as zinc oxide, magnesium oxide, and lead oxide.
[00012]
Various methods for minimizing or eliminating Type IV allergic reactions
caused by vulcanization accelerators have been attempted, including
crosslinking
without the use of sulfur and vulcanization accelerators. Approaches include
(a)
crosslinking using gamma irradiation, (b) crosslinking using organic
peroxides, (c)
crosslinking using zinc oxide alone, via carboxyl-zinc ionic bonding, and (d)
introducing
functional groups into the polymer backbone that can form crosslinks after the
product
has been fabricated. Generally speaking, all of these approaches suffer from
drawbacks. For example, approaches (a) and (b) result in products having
poorer
physical properties and poorer aging resistance than sulfur-vulcanized
products.
-3-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00013] Another
approach is the use of safer accelerators. These are accelerators
that have a lower allergenic potential. For example, a high-molecular weight
accelerator
that has low allergenic potential may be used, including, e.g., zinc dibenzyl
dithiocarbamate (ZBEC), and zinc diisononyl dithiocarbamate (ZDNC). By virtue
of their
high molecular weights, these types of accelerators are more compatible with
natural
rubber and synthetic polyisoprene rubber, and therefore have a higher
solubility in the
rubber matrix. As a result, very little of the high-molecular weight
accelerator would
bloom to the rubber surface and come in contact with the user to cause a
potential
allergic reaction. For the
same reason, very little of the high-molecular weight
accelerator can be extracted from the rubber. ZDNC is preferred over ZBEC
because it
has a higher solubility in natural rubber (about 3% weight/weight), whereas
the solubility
of ZBEC is only about 0.5% weight/weight.
[00014] A
further approach is to use combinations of fugitive accelerators, i.e.,
accelerators that are completely used up during vulcanization, leaving no
residue in the
product. Examples of such fugitive accelerators include xanthates, such as
diisopropyl
xanthogen polysulfide (DIXP), or dibutyl xanthogen disulfide (DBXD).
Heating DIXP
alone to high temperatures does not volatalize or decompose it completely to
gaseous
products. However, when DIXP is used together with sulfur and zinc oxide for
crosslinking a diene containing polymer or rubber, it is consumed completely
to form
sulfur crosslinks, isopropanol and carbon disulfide as the major reaction
products,
leaving behind virtually no residue on the polymer or rubber since isopropanol
and
carbon disulfide would volatilize at the crosslinking/vulcanization
temperatures. Since
DIXP does not contain nitrogen in its chemical structure, it is also
impossible to
generate N-nitrosamines, which are associated with thiuram and dithiocarbamate

accelerators. Additionally, certain nitrosamines are believed to be
carcinogenic, and
their formation should be avoided. However, DIXP alone does not accelerate
sulfur
crosslinking sufficiently to produce enough sulfur crosslinks to yield useful
products.
The resulting articles have a tensile strength that is too low. Hence, DIXP
has always
been used in conjunction with another accelerator.
[00015] A
variety of accelerator compositions have been disclosed in the prior art,
some of which are discussed below.
-4-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00016] U.S. Published Application No. 2003/0161975 discloses the use of
sulfur
and DIXP, together with tetrabenzyl thiuram disulfide or ZBEC to produce
polyisoprene
condoms that are defect-free. The latex compound has improved stability
compared to
latexes formed using conventional accelerators such as zinc diethyl
dithiocarbamate
and zinc dibutyl dithiocarbamate.
[00017] A synergistic combination of DIXP and ZDNC has been recommended as
a safer accelerator for use with natural rubber latex and synthetic
polyisoprene latex.
Chakraborty et al., "Novel Sustainable Accelerators for Latex Applications ¨
Update,"
International Latex Conference (2005).
[00018] For vulcanizing polychloroprene, conventional curing packages
include
sulfur, non-fugitive accelerators, and zinc oxide. Non-fugitive accelerators
that are used
include zinc dibutyl dithiocarbamate (ZDBC); a mixture of tetraethylthiuram
disulfide and
sodium dibutyl dithiocarbamate; and a mixture of diphenyl thiourea
(thiocarbanilide) and
diphenyl guanidine (see Carl, Neoprene Latex, chapter 3, published by E.I., du
Pont de
Nemours & Co. (1962)). However, residuals of these non-fugitive accelerators
in the
product can induce Type IV allergic reactions,
[00019] Chakraborty et al. (2nd International Rubber Glove Conference 2004,
Kuala Lumpur, Malaysia) disclosed formulations using sulfur, two combinations
of two
accelerators (ZDNC and DIXP, or ZDEC and MBT), zinc oxide, and two
antioxidants
(A02246 and MMBI).
[00020] Jole Van (WO 2007/017368) also disclosed formulations using sulfur,
accelerators (DIXP and alkyl dithiocarbamates of various chain lengths, such
as ZDNC,
and DPG), zinc oxide, and an antioxidant (Aquanox L).
[00021] Lucas (WO 2003/072340) disclosed formulations using sulfur,
accelerators (various combinations comprising DIXP, DIX, XS, TETD, TBeTD, and
ZDBeC), zinc oxide, and an antioxidant (Wingstay L).
[00022] Sparks et al. (U.S. Patent No. 3,378,538) discloses a process for
preparing a sulfur-modified polychloroprene by polymerizing in the presence of
sulfur
and a dialkyl xanthogen disulphide.
[00023] Collette et al. (U.S. Patent No. 3,397,173) discloses a process for
polymerizing chloroprene and sulfur in an aqueous emulsion to form a latex.
The
-5-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
polymerization is conducted in the presence of sulfur, dialkyl xanthogen
disulfide, and
an antioxidant.
[00024]
Takeshita (U.S. Patent No. 4,605,705) disclose a heat-resistant, sulfur-
modified polychloroprene copolymer of 2-chloro-1,3-butadiene and 2,3-dichloro-
1,3-
butadiene formed using elemental sulfur, and diisopropyl xanthogen disulfide
or an
equivalent amount of a dialkyl xanthogen disulfide, such as dibutyl xanthogen
disulfide.
[00025]
Accordingly, there is a need in the art for vulcanization compositions used
to vulcanize elastomeric articles, where the vulcanization compositions have
reduced
allergenic potential as compared to elastomeric articles formed using
vulcanization
compositions having non-fugitive accelerator compositions. The present
invention also
relates to polychloroprene-based elastomeric articles formed using the
vulcanization
compositions. The invention also relates to methods for making a reduced
allergenicity
vulcanization composition, and to methods for using the vulcanization
compositions to
vulcanize elastomeric articles.
Summary of the Invention
[00026] The
present invention provides vulcanization compositions having
accelerator compositions that are used to vulcanize elastomeric articles.
The
vulcanization compositions have reduced allergenic potential as compared to
vulcanization compositions having non-fugitive accelerator compositions, and
may be
used to form elastomeric articles that have reduced allergenic potential as
compared to
elastomeric articles formed using vulcanization compositions having non-
fugitive
accelerator compositions. Non-fugitive accelerator compositions may include
thiazoles,
thiurams, carbamates, guanidines, and thioureas. The present invention also
relates to
polychloroprene-based elastomeric articles formed using the vulcanization
compositions. The
invention further relates to methods for making a reduced
allergenicity vulcanization composition, and to methods for using the
vulcanization
compositions to vulcanize elastomeric articles.
[00027] The
present invention meets the unmet needs of the art, as well as others,
by providing vulcanization compositions, latex dispersions, and elastomeric
articles that
exhibit reduced or eliminated allergic potential as compared to vulcanization
-6-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
compositions, latex dispersions, and elastomeric articles formed using
conventional
techniques. According to some aspects, the present invention results in
reduced or
eliminated Type I and Type IV allergenicity. The vulcanization compositions,
latex
dispersions, elastomeric articles, and methods of the present invention are
beneficial for
avoiding problems associated with allergic reactions to elastomeric articles,
particularly
in the medical field, where both health care providers and patients are
exposed to these
potential sources of allergens frequently and/or for extended periods of time.
[00028]
According to one aspect of the invention, the invention relates to a
vulcanization composition comprising sulfur, a single fugitive xanthate
accelerator, and
a metal oxide, where the vulcanization composition does not include an
additional
accelerator. According to another aspect of the invention, the invention
relates to a
vulcanization composition comprising sulfur, one or more fugitive xanthate
accelerators,
and a metal oxide, where the composition does not include a non-fugitive
accelerator.
According to some aspects, the vulcanization composition exhibits reduced
allergenicity
as compared to vulcanization compositions comprising non-fugitive
accelerators.
[00029]
According to another aspect of the invention, the vulcanization
composition comprises sulfur, diisopropyl xanthogen polysulfide, and a metal
oxide, and
does not include an additional accelerator. According to another aspect of the

invention, the vulcanization composition comprises sulfur, diisopropyl
xanthogen
polysulfide, and a metal oxide, and does not include a non-fugitive
accelerator.
According to some aspects, the vulcanization composition exhibits reduced
allergenicity
as compared to vulcanization compositions comprising non-fugitive
accelerators.
[00030]
According to yet another aspect of the invention, the vulcanization
composition consists of sulfur, an accelerator composition including
diisopropyl
xanthogen polysulfide, and an activator including a metal oxide. According to
some
aspects, the accelerator composition exhibits reduced allergenicity as
compared to non-
fugitive accelerators.
[00031] Still
another aspect of the invention provides a latex dispersion comprising
an elastomer and a vulcanization composition comprising sulfur, a single
fugitive
xanthate accelerator, and a metal oxide, where the composition does not
include an
additional accelerator.
Another aspect of invention provides a latex dispersion
-7-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
comprising an elastomer and a vulcanization composition comprising sulfur, one
or
more fugitive xanthate accelerators, and a metal oxide, where the composition
does not
include a non-fugitive accelerator. According to some aspects, the elastomeric
articles
exhibit reduced allergenicity as compared to elastomeric articles formed using
non-
fugitive accelerators. According to further aspects, the elastomer is
polychloroprene.
According to still further aspects, the latex formulation may be used to form
elastomeric
articles that may include, but are not limited to, gloves (specifically
medical gloves, and
more specifically examination and surgical gloves), as well as condoms, probe
covers,
dental dams, finger cots, and catheters.
[00032] According to further aspects of the invention, a method of
preparing a
reduced-allergenicity vulcanization composition is provided, in which sulfur,
a single
fugitive xanthate accelerator, and a metal oxide are combined. The method does
not
include a step of providing an additional accelerator composition. According
to another
aspect of the invention, a method of preparing a reduced-allergenicity
vulcanization
composition is provided, in which sulfur, one or more fugitive xanthate
accelerators, and
a metal oxide are combined. The method does not include a step of providing a
non-
fugitive accelerator.
[00033] According to still further aspects of the invention, a method of
preparing a
reduced-allergenicity elastomeric article is provided, in which a latex
dispersion is
formed that includes vulcanization composition comprising sulfur, a single
fugitive
xanthate accelerator, and a metal oxide, and the latex dispersion is used to
form an
elastomeric article. In some aspects, the elastomeric article may be formed by
the
coagulant dipping method. The method does not include a step of adding another

accelerator composition to form the article. According to another aspect of
the
invention, a method of preparing a reduced-allergenicity elastomeric article
is provided,
in which a latex dispersion is formed that includes a vulcanization
composition
comprising sulfur, one or more fugitive xanthate accelerators, and a metal
oxide, and
the latex dispersion is used to form an elastomeric article. The method does
not include
a step of adding a non-fugitive composition to form the article.
-8-

According to further aspects of the invention, there is provided a method for
preparing a
reduced-allergen icity polychloroprene elastomeric article, comprising:
providing a latex
dispersion, coating a former with the latex dispersion by coagulant dipping to
form a first
elastomeric layer, and drying and vulcanizing the first elastomeric layer. The
latex dispersion
comprises polychloroprene and a vulcanization composition. The vulcanization
composition
consists of elemental sulfur, diisopropyl xanthogen polysulfide, and a metal
oxide. The latex
dispersion does not include any additional compounds that function as
accelerators for
vulcanizing elastomers.
The method may further comprise coating the former coated with the first
elastomeric
layer with a second latex dispersion to form a second elastomeric layer. The
second
elastomeric layer may be applied prior to drying and vulcanizing the first
elastomeric layer. The
second elastomeric layer may be formed from a second latex dispersion
comprising a polymer
latex selected from the group consisting of natural rubber, polyurethane,
polybutadiene,
polychloroprene, nitrile rubber, block copolymers of styrene and butadiene,
block copolymers
of styrene and isoprene, and synthetic polyisoprene.
According to further aspects of the invention, there is provided a coating for
an
elastomeric article, comprising: a latex dispersion: a second polymer latex
dispersion
comprising a polymer latex selected from the group consisting of natural
rubber, polyurethane,
polybutadiene, polychloroprene, nitrile rubber, block copolymers of styrene
and butadiene,
block copolymers of styrene and isoprene, and synthetic polyisoprene; and
water. The latex
dispersion comprises polychloroprene and a vulcanization composition. The
vulcanization
composition consists of elemental sulfur, diisopropyl xanthogen polysulfide,
and a metal oxide.
The latex dispersion does not include any additional compounds that function
as accelerators
for vulcanizing elastomers. The total solids content of the second polymer
latex dispersion is
from about 3% to about 15%.
The polymer latex may be selected from the group consisting of nitrite rubber
and
synthetic polyisoprene.
According to further aspects of the invention, there is provided a method for
preparing a
red uced-allergenicity polychloroprene elastomeric article, comprising:
providing a latex
dispersion, coating a former with the latex dispersion by coagulant dipping to
form a first
-8a-
CA 2802956 2017-08-17

elastomeric layer, and drying and vulcanizing the first elastomeric layer. The
latex dispersion
comprises polychloroprene and a vulcanization composition. The vulcanization
composition
consists of: elemental sulfur, diisopropyl xanthogen polysulfide, and a metal
oxide. The latex
dispersion does not include any non-fugitive accelerators.
The method may further comprise coating the former coated with the first
elastomeric
layer with a second latex dispersion to form a second elastomeric layer. The
second
elastomeric layer may be applied prior to drying and vulcanizing the first
elastomeric layer. The
second elastomeric layer may be formed from a second latex dispersion
comprising a polymer
latex selected from the group consisting of natural rubber, polyurethane,
polybutadiene,
polychloroprene, nitrile rubber, block copolymers of styrene and butadiene,
block copolymers
of styrene and isoprene, and synthetic polyisoprene.
According to further aspects of the invention, there is provided a coating for
an
elastomeric article, comprising: a latex dispersion; a second polymer latex
dispersion
comprising a polymer latex selected from the group consisting of natural
rubber, polyurethane,
polybutadiene, polychloroprene, nitrile rubber, block copolymers of styrene
and butadiene,
block copolymers of styrene and isoprene, and synthetic polyisoprene; and
water. The latex
dispersion comprises polychloroprene and a vulcanization composition. The
vulcanization
composition consists of: elemental sulfur, diisopropyl xanthogen polysulfide,
and a metal oxide.
The latex dispersion does not include any non-fugitive accelerators. The total
solids content of
the second polymer latex dispersion is from about 3% to about 15%.
The polymer latex may be selected from the group consisting of nitrile rubber
and
synthetic polyisoprene.
-8b-
CA 2802956 2017-08-17

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00034] Other
novel features and advantages of the present invention will become
apparent to those skilled in the art upon examination of the following or upon
learning by
practice of the invention.
Detailed Description of the Preferred Embodiments
[00035] The
present invention generally relates to vulcanization compositions
including accelerator compositions used to vulcanize elastomeric articles,
where the
accelerator compositions have reduced allergenic potential as compared to
elastomeric
articles formed using vulcanization compositions having non-fugitive
accelerator
compositions. The vulcanization compositions comprise sulfur, zinc oxide, and
a
fugitive vulcanization accelerator. The
present invention also relates to latex
dispersions and elastomeric articles formed using the vulcanization
compositions. The
present invention further relates to methods for making a reduced
allergenicity
vulcanization composition, and to methods for using the vulcanization
compositions to
vulcanize elastomeric articles.
[00036]
Fugitive vulcanization accelerators for use in accordance with the present
invention include xanthates. Diisopropyl xanthogen polysulfide (DIXP) and
dialkyl
xanthogen disulfides are preferred fugitive xanthates that may be used in
accordance
with the present invention, and it is envisioned that additional fugitive
xanthates that
may be developed in the future will also find use in the accelerator
compositions, latex
dispersions, and elastomeric articles of the present invention. Fugitive
xanthates are
useful in the accelerator compositions of the vulcanization compositions of
the present
invention because during vulcanization they are consumed by bonding to the
rubber
matrix, and form gases and/or volatile liquids as by-products that evaporate,
thereby
leaving no residue on the elastomeric article. In the case of diisopropyl
xanthogen
polysulfide (DIXP), the compound form isopropyl alcohol and carbon disulfide
gas as
by-products.
[00037] The
present invention also provides elastomeric articles made from
polychloroprene rubber and vulcanized using sulfur, zinc oxide, and DIXP.
According to
some aspects, the elastomeric articles may include gloves (specifically
medical gloves,
and more specifically examination and surgical gloves), as well as condoms,
probe
-9-

covers, dental dams, finger cots, and catheters. According
to certain aspects
polychloroprene surgical and examination gloves made using such an accelerator

composition are provided.
[00038] Elastomeric
articles made using non-fugitive accelerator compositions
contain residual accelerators that could cause Type IV allergy reactions in
humans, and
elastomeric articles made using natural rubber contain extractable latex
proteins that
are linked to Type I allergy reactions in humans. Because the elastomeric
articles,
accelerator compositions, latex compositions, methods of making accelerator
compositions, and methods of vulcanizing elastomeric articles in accordance
with the
present invention do not incorporate natural rubber, and do not have residual
accelerators included therein, the potential for Type I allergic reactions and
Type IV
allergic reactions is reduced or eliminated. Non-fugitive accelerator
compositions may
include thiazoles, thiuranns, carbamates, and the like, which are known to
cause Type
IV allergy reactions in humans. Other non-fugitive accelerators such as
guanidines and
thioureas have also been used in rubber gloves.
[00039] The
compositions and methods of the invention will be described in
greater detail below.
Vulcanization Compositions
[00040] The
vulcanization compositions of the present invention preferably include
a source of sulfur, an accelerator composition, and an activator. The
accelerator
compositions may include a fugitive accelerator. According to certain aspects
of the
invention, in which the allergenicity of the vulcanization composition is
being minimized
or eliminated, elemental sulfur and a single xanthate fugitive accelerator are
used. In
another aspect elemental sulfur and one or more xanthate fugitive accelerators
are
used and a non-fugitive accelerator is not included. The accelerator is in a
range from
about 0.1 to about 10 parts by dry weight rubber, preferably from about 0.5 to
about 5
parts by dry weight rubber, and more preferably about 1 to about 4 parts by
dry weight
rubber. The vulcanization compositions may be used to vulcanize elastomers
including
natural rubber, polyurethane, polybutadiene, polychloroprene (Neoprene),
nitrile rubber,
block copolymers of styrene and butadiene, block copolymers of styrene and
isoprene,
-10-
CA 2802956 2017-08-17

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
and polyisoprene. In certain preferred aspects of the invention, the elastomer
is
polychloroprene.
[00041] In
aspects of the invention in which the allergenicity of the vulcanization
composition is being minimized or eliminated altogether, the source of sulfur
used in the
vulcanization composition comprises elemental sulfur. According to certain
aspects of
the invention, only elemental sulfur is used.
[00042] The
vulcanization activator may include, but is not limited to, zinc oxide,
magnesium oxide, lead oxide, and combinations thereof. Zinc oxide is used as a

vulcanization activator in certain aspects of the invention. The activator is
in a range
from about 0.1 to about 15 parts by dry weight rubber, preferably from about 6
to about
12 parts by dry weight rubber, and more preferably from about 5 to about 13
parts by
dry weight rubber.
[00043] In
aspects of the invention in which the allergenicity of the vulcanization
composition is being minimized or eliminated altogether, the vulcanization
accelerator
used in accordance with aspects of the invention is a fugitive xanthate.
According to
some aspects, the fugitive xanthate is a polysulfide that includes more than
two sulfide
groups, i.e., three or more sulfide groups (trisulfide), four or more sulfide
groups
(tetrasulfide), five or more sulfide groups (pentasulfide), etc. According to
further
aspects of the invention, the fugitive xanthate is diisopropyl xanthogen
polysulfide
(DIXP) or a dialkyl xanthogen disulfide, such as dibutyl xanthogen disulfide,
and
diisopropyl xanthogen disulfide. It
should be noted that these fugitive xanthate
accelerators can also serve as sulfur donors. In an aspect of the invention,
the sulfur
donor has a low allergenic potential. The elemental sulfur or sulfur donor is
in a range
from about 0.1 to about 5 parts by dry weight rubber, preferably from about
0.5 to about
2 parts by dry weight rubber, and more preferably from about 1.2 to 1.5 parts
by dry
weight rubber.
[00044] In
certain aspects of the invention, only a single fugitive xanthate
vulcanization accelerator is used in the accelerator composition, and any
additional
vulcanization accelerators are excluded from the accelerator composition. In
another
aspect one or more fugitive xanthate accelerators may be used, and a non-
fugitive
accelerator is not used.
-11-

[00045] According
to further aspects of the invention, DIXP is used as the sole
vulcanization accelerator, and is the only compound that functions as a
vulcanization
accelerator that is included in the accelerator composition. When
accelerator
compositions having reduced or eliminated allergenicity are prepared in
accordance
with the present invention, they may beneficially comprise only DIXP as a
fugitive
accelerator. Any additional compounds that may also function as vulcanization
accelerators are excluded from the accelerator compositions. In another
aspect,
additional fugitive accelerators may be included in the accelerator
compositions, but
additional non-fugitive accelerators are excluded. The exclusions in either
aspect are
beneficial because the presence of any additional vulcanization accelerators
or the use
of non-fugitive accelerators increases the likelihood that an allergic
reaction, particularly
a Type IV allergic reaction, may occur in a user of an elastomeric article
formed with the
vulcanization composition.
Latex Dispersions and Elastomeric Articles
[00046] The
vulcanization compositions of the present invention may be used to
prepare latex dispersions. The latex dispersion may comprise an elastomer that
may
be selected from natural rubber, polyurethane, polybutadiene, polychloroprene
(Neoprene), nitrile rubber, block copolymers of styrene and butadiene, block
copolymers of styrene and isoprene, and polyisoprene. According to certain
aspects, a
particularly preferred elastomer for use in the latex dispersions of the
invention is
polychloroprene. These latex dispersions may comprise, in addition to the
elastomer
and vulcanization composition, one or more different non-curing ingredients.
The non-
curing ingredients may include, but are not limited to, antioxidants,
stabilizers,
plasticizers, anti-ozone agents, pigments, and fillers. According to an aspect
of the
invention, when making the first elastomeric layer (base glove), the total
solids content
of the latex dispersion is in a range from about 20% to about 45%. According
to some
aspects of the invention for preparing a coating composition suitable for
forming a
second, third, fourth, etc. elastomeric layer (e.g., as described in U.S.
Published Appl.
No. 2008/0190322 Al), the total
solids content of the latex dispersion is adjusted so that it is in a range of
from about 1%
-12-
CA 2802956 2017-08-17

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
to about 20%, preferably from about 2% to about 17%, and more preferably from
about
3% to about 15%. According to one aspect of the invention, the total solids
content of
the latex dispersion is about 5%. According to other aspects of the invention
for
preparing a single layer glove, or the first elastomeric layer of a glove
having two or
more layers, the total solids content of the latex dispersion is generally in
the range of
from about 20% to about 45%, preferably from about 25% to about 40%.
[00047] The latex dispersions of the present invention that contain an
elastomer
and vulcanization composition may be used in methods for preparing elastomeric

articles such as gloves, specifically medical gloves, and more specifically
examination
and surgical gloves. However, it is considered within the ability of those
skilled in the art
to prepare alternative elastomeric articles other than gloves, including, but
not limited to,
condoms, probe covers, dental dams, finger cots, catheters, and the like,
using the
guidance provided herein.
[00048] The elastomeric articles of the present invention that are formed
using the
vulcanization compositions and/or latex dispersions described above may be
produced
using any conventional manufacturing methods, e.g., coagulant dipping. In the
"anode"
coagulant-dipping process, a coagulant-coated former is dipped into the
dispersion, and
is then cured to form a finished article. In the "Teague" coagulant-dipping
process, the
former is dipped into the dispersion, and is then dipped into a coagulant,
followed by
curing to form a finished article. These methods utilize dispersions
containing the
elastomer from which the finished article is to be formed. Preferred
elastomers include
natural rubber, polyurethane, polybutadiene, polychloroprene (Neoprene),
nitrile rubber,
block copolymers of styrene and butadiene, block copolymers of styrene and
isoprene,
and polyisoprene. According to certain aspects, a particularly preferred
elastomer is
polychloroprene. According to still further aspects, a polychloroprene
elastomeric article
is provided that is vulcanized using an vulcanization composition consisting
of sulfur,
zinc oxide, and DIXP.
[00049] In prior art compositions, DIXP has always been used in combination
with
additional accelerators including non-fugitive accelerators, because it is not
sufficiently
active on its own to form adequate numbers of sulfur crosslinks to form a
useful
elastomeric article. However, the present invention has unexpectedly
discovered that it
-13-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
is possible to vulcanize polychloroprene latex with a vulcanization
composition
consisting of sulfur, DIXP, and zinc oxide in order to obtain an elastomeric
article having
a tensile strength that meets the ASTM D6977-04 requirements for
polychloroprene
examination gloves (minimum 14 MPa), as well as the ASTM D3577-01 requirements

for synthetic latex surgical gloves (minimum 17 MPa). Because DIXP is a
fugitive
xanthate, and no DIXP residue remains on the gloves following vulcanization,
the
gloves produced using this vulcanization composition exhibit low allergenic
potential.
[00050] Polychloroprene rubber can form crosslinks between polymer chains
in
the presence of a catalyst, such as zinc oxide, magnesium oxide, or lead
oxide, unlike
natural rubber or synthetic polyisoprene rubber. Without wishing to be bound
by theory,
this crosslinking is believed to occur as a result of a bis-alkylation
mechanism that is
specific to polychloroprene due to its chemical structure. The crosslinking
between
polymer chains is believed to take place at sites on the polymer chain where
there are
reactive tertiary allylic chlorine atoms formed by 1,2-polymerization of
chloroprene
monomers. The labile chlorine amounts to about 1.5% of the total chlorine in
the
polychloroprene polymers. In addition to this type of crosslinking, it is also
possible that
sulfur crosslinking could occur at other sites on the polymer chain. See Carl,
Neoprene
Latex, chapter 3.
[00051] The elastomeric articles of the present invention may be formed
using
latex dispersions containing any additives components that may be used in
forming the
elastomeric articles, which may include at least one of curing ingredients,
non-curing
ingredients, and additional polymers, to be discussed below, with the same,
similar or
different chemical structures from the elastomer. The total amount of
additive(s) used is
about 0.5-49% by weight of total dispersion phase solids.
[00052] When curing using sulfur, the main curing agent preferably
comprises
elemental sulfur and/or a sulfur donor that has low or no allergenic
potential. According
to certain aspects of the invention, only elemental sulfur is used.
[00053] Activators may include, but are not limited to, zinc oxide,
magnesium
oxide, and lead oxide. Zinc oxide is the most commonly used vulcanization
activator.
[00054] Vulcanization accelerators in accordance with the invention are
fugitive
xanthates. According to further aspects of the invention, the fugitive
xanthate is
-14-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
diisopropyl xanthogen polysulfide (DIXP) or a dialkyl xanthogen disulfide,
such as
dibutyl xanthogen disulfide, and diisopropyl xanthogen disulfide.
[00055] Any non-
curing ingredients that are conventionally used in elastomer
dispersion compounding formulations may be used in the present invention. For
example, the non-curing ingredients may include, but are not limited to,
antioxidants,
stabilizers, plasticizers, anti-ozone agents, pigments, and fillers.
[00056]
Suitable antioxidants that may be added to the elastomer dispersion
include, but are not limited to, hindered phenols such as butylated
hydroxytoluene (2,6-
d i-tert-butyl-4-methylphenol) and
thiodiethylene bis-di-t-butyl-4-hydroxyphenyl
propionate, hindered polyphenolics such as butylated reaction products of p-
cresol and
dicyclopentadiene, hindered phenol/hindered polyphenolics such as trimethyl-
tris (di-t-
buty1-4-hydroxybenzym)-benzene or octadecyl di-t-buty1-4-hydroxyphenyl
propionate,
amines such as a blend of 6PPD with methyl styrene and bis-alpha-
dimethylbenzyl
diphenyl amine, mixtures such as zinc mercaptotulumimidazole/phenolic,
triazinone
derivatives such as triazinone-phenol mixtures, polyaromatic amines such as
poly(m-
anisidine), phenolic antioxidant hydrazides such as phenolics with anhydride
copolymer,
phenolics such as 2,2'-methylene-bis-(4-methyl-6-t-butylphenol), cresols such
as 2,4-
dimethy1-6-(1-methylcyclohexyl)-p-cresol, and styrenated phenols. One
particularly
preferred antioxidant is butylated reaction products of p-cresol and
dicyclopentadiene
(e.g., Wingstay L).
[00057]
Colloidal stabilizers including alkalis for pH adjustment, surfactants and
alkaline caseinates such as sodium caseinate may also be added to the aqueous
phase.
[00058]
Suitable plasticizers that may be added to the elastomer dispersion may
include, but are not limited to, fatty salts, mineral oils and ester
plasticizers.
[00059]
According to some aspects, an antiozonant is added to an elastomer
dispersion that is used to make the elastomeric articles of the invention.
Ozone can
severely damage some elastomeric articles, such as those formed from polymers
that
are highly unsaturated, like polyisoprene. When included in the aqueous
elastomer
dispersion of the invention, certain high molecular weight polymers, such as
waxes,
EPDM and hydrogenated polydiene can provide such articles with excellent ozone
-15-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
resistance. Waxes form a physical barrier at the surface of the rubber which
protects
against ozone attack. There are two types of waxes: straight chain paraffin
waxes and
branched-chain microcrystalline waxes. The most widely used antiozonant waxes
are
blends of paraffin and microcrystalline waxes for maximum protection over a
broad
range of exposure temperatures. Paraffin waxes are straight-chain hydrocarbon
molecules containing about 20 to 50 carbon atoms. Suitable paraffin waxes have
a
melting point of from about 50 to 75 C, preferably 52 to 68 C.
Microcrystalline waxes
are also known as amorphous waxes and are hydrocarbons, similar to paraffin
waxes,
but the carbon chains are branched and have higher molecular weight of about
40 to 70
carbon atoms per chain. Other examples of antiozonants that may be used in the

invention may include, but are not limited to, alkyl/aryl p-phenylenediamines
such as N-
1,3-dimethylbutyl-N'-phenyl-p-phenylenediamine 6PPD,
organoclay-antiozonant
complexes such as smectite-containing clay with alkyl-aryl-p-phenylenediamine,

functionalized benzotriazoles such as N,N-disubstituted para-phenylenediamine,

triazines such as tris (N-1,4-dimethylpentyl-p-phenylenediamino) 1,3,5-
triazine and tris
(N-alkyl-p-phenylenediamino) 1,3,5-triazine, and p-phenylenediamines such as N-

isopropyl-N'-phenyl-p-phenylenediamine (IPPD). In addition, polymers including
waxes
such as paraffinic wax (MW=300-500), microcrystalline wax (MW=600-700) (with
paraffinic wax) and low MW PE wax (MW=100-1100), polymeric antiozonants such
as
polymeric diphenyldiamine, and ozone inert polymers such as EPDM and
brominated
isobutylene/para-methylstyrene copolymer (BIMSM) may be used as antiozonants.
It is
preferred that waxes are used. Once particularly preferred wax is Michem Lube
180.
Another preferred wax dispersion is Antilux 600.
[00060]
Suitable pigments that may be added to the aqueous elastomer dispersion
may include a wide range of natural pigments such as titanium dioxide and iron
oxides,
and synthetic pigments.
[00061]
Suitable fillers that may be added to the aqueous elastomer dispersion
may include, but are not limited to, inorganic fillers such as clays, calcium
carbonate,
talc, and silica and organic fillers such as crosslinked polymethyl
methacrylate, finely
divided urethane resin particles and polyethylene microspheres.
-16-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00062] Additional polymers may also be incorporated into the latex
dispersions
and elastomeric articles of the present invention. This may be done to provide

additional functionality or impart beneficial properties to the latex
dispersions and
elastomeric articles. Such functions/properties may include, but are not
limited to,
improved damp/wet donning, improved fluid repellency, improved resistance to
microorganisms, improved resistance to degradation, etc. According to some
aspects
of the invention, the additional polymer is selected from natural rubber,
polyurethane,
polybutadiene, polychloroprene (Neoprene), nitrile rubber, block copolymers of
styrene
and butadiene, block copolymers of styrene and isoprene, and polyisoprene.
When
present, the additional polymer may be provided in an amount that is from
about 5% to
about 200% of the primary polymer, preferably from about 25% to about 150%,
more
preferably from about 50% to about 125%, and still more preferably from about
75% to
about 100%. One exemplary latex dispersion containing additional polymers
includes
2.5% polychloroprene, 2.5% synthetic polyisoprene, and 95% water (i.e., the
additional
polymer, polyisoprene, is provided in an amount that is 100% of the amount of
the
primary polymer, polychloroprene). Another exemplary latex dispersion
containing
additional polymers includes 2.5% polychloroprene, 2.5% nitrile, and 95%
water.
[00063] According to some aspects of the invention, elastomeric articles
are
provided that include multiple elastomeric layers, where the multiple
elastomeric layers
may have the same or different compositions. For example, a coating comprising

synthetic polyisoprene blended with polychloroprene may be applied to a
polychloroprene elastomeric article to provide improved damp/wet donning
characteristics to the article. In another example, a coating composition
comprising
nitrile blended with polychloroprene may be applied to a polychloroprene
elastomeric
article to provide improved damp/wet donning characteristics to the article.
[00064] According to further aspects of the invention, the elastomeric
articles may
be formed either with, or without, powder or starch. Although powder and
starch are
commonly-used donning agents, they could be also associated with allergic
reactions,
and therefore another aspect of the invention relates to powder-free and
starch-free
elastomeric articles. Further aspects relate to substantially power-free and
starch-free
elastomeric articles in which less than 5 mg of powder or starch, preferably
less than 3
-17-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
mg of powder or starch, more preferably less than 2 mg of power or starch, and
most
preferably less than 1 mg of powder or starch. These articles are prepared
using the
vulcanization compositions described above.
[00065] These and other aspects of the invention are further described in
the non-
limiting Examples set forth below.
EXAMPLES
Example 1 ¨ Commercial powder-free polychloroprene gloves
[00066] A commercially available powder-free polychloroprene surgical glove
(Duraprene SMT by Cardinal Health) is formed using a vulcanization composition

comprising sulfer, zinc dibutyl dithiocarbamate, and zinc oxide. The unaged
and aged
properties of the gloves are shown in Table 1.
Table 1 ¨ Physical Properties of Powder-Free Duraprene SMT Gloves
Properties Unaged Aged (7 days,
70 C)
Tensile Strength, MPa 19.6 19.1
Tensile Stress @500%, MPa 1.86
Ultimate Elongation, % 1003 888
Example 2 ¨ Preparation of powdered gloves
[00067] Polychloroprene latex was compounded using a formulation comprising
either Formulation A (comparative formulation), which includes only zinc oxide
as curing
agent, or Formulation B, which includes a combination of sulfur, zinc oxide,
and DIXP
as curing agent. The complete compounding formulations are set forth in Table
2.
-18-

Table 2 ¨ Compounding Formulations
Ingredient Parts per weight
Parts per weight
dry rubber (phr) dry rubber (phr)
Formulation A Formulation B
TM ________________________________________________________
Neoprene 750 Latex 100.00 100.00
Darvan SMO Solution 4.50 4.50
Darvan WAQ Solution 1.50 1.50
Unifg126 Solution 0.50 0.50
Zinc Oxide Dispersion 12.00 12.00
Sulfur Dispersion 0.00 1.50
Robac AS100 (D)XP) 0.00 2.00
Wingstay L 0.75 0.75
Michemlube 180 1.00 1.00
Rocifht 0 0.028 0.028
___________ TM __________
Triton X-100 0.013 0.013
Titanium Dioxide 0.200 0.200
Dispersion
Pigment 0.080 0.080
-19-
CA 2802956 2017-08-17

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00068] Gloves were formed by the standard coagulant dipping process, and
were
vulcanized using hot air. The properties of the gloves are shown in Table 3.
Table 3 ¨ Physical Properties of Polychloroprene Gloves
Properties Formulation A Formulation B
Tensile Strength, MPa 12.00 23.00
Tensile Stress @300%, MPa 0.88 1.47
Tensile Stress @500%, MPa 1.08 2.55
Ultimate Elongation, % 1160 904
[00069] The gloves cured only with zinc oxide exhibited a tensile strength
of 12
MPa, which was not sufficient to meet ASTM requirements for either examination
or
surgical gloves. However, the inventive gloves cured with a combination of
sulfur, zinc
oxide, and DIXP exhibited a tensile strength of 23 MPa, which exceeded the
ASTM
requirements for polychloroprene examination gloves and surgical gloves made
from
synthetic latex.
Example 3 ¨ Preparation of powder-free gloves
[00070] Powder-free polychloroprene gloves were prepared by forming a base
glove layer using the standard coagulant dipping process, and using the
compounded
latex of Formulation B or the compounded latex of Formulation C. The latex
formulations are set forth below in Table 4.
-20-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
Table 4¨ Compounding Formulation
Ingredient Parts per weight Parts per weight
dry rubber (phr) dry rubber (phr)
Formulation B Formulation C
Neoprene 750 Latex 100.00 100.00
Darvan SMO 4.50 4.50
Solution
Darvan WAQ 1.50 1.50
Solution
Uniflo 26 Solution 0.50 0.50
Zinc Oxide 12.00 6.00
Dispersion
Sulfur Dispersion 1.50 1.20
Robac AS100 2.00 3.00
(DIXP)
Wingstay L 0.75 0.75
Michemlube 180 1.00 1.00
Rodo # 0 0.028 0.028
Triton X-100 0.013 0.013
Titanium Dioxide 0.200 0.200
Dispersion
Pigment 0.080 0.080
[00071] The former bearing the wet base glove layer was then leached in
water,
and after partial drying was dipped into a blend of compounded polychloroprene
latex
and nitrile latex so as to form a thin coating of the latex blend onto the
base glove layer.
The rubber latex blend comprised about 2.5% compounded polychloroprene latex
and
2.5% nitrile latex, and about 95% water. Formulations B and C were used as the

formulation for the blend of compounded polychloroprene latex with nitrile
latex. For
-21-.

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
example, if Formulation B compounded polychloroprene latex is used for dipping
the
base polychloroprene glove, then a coating composition having 5% total solids
content
would contain a blend of 2.5% Formulation B compounded polychloroprene latex
and
2.5% raw nitrile latex. Similarly, if Formulation C compounded polychloroprene
latex is
used for dipping the base polychloroprene glove, then a coating composition
having 5%
total solids content, the coating composition would contain, for example, a
blend of
2.5% Formulation C compounded polychloroprene latex and 2.5% raw nitrile
latex.
While generally it is convenient for the coating composition to use a blend of
raw nitrile
latex and compounded polychloroprene latex using the same compounding
formulation
as that used for the polychloroprene latex for making the base glove, it is
possible that
the compounding formulations for the base glove and the coating layer be
different. For
example, it is possible to use Formulation C for making the base glove and
Formulation
B to blend with raw nitrite latex for coating the base glove.
[00072] The former was withdrawn from the latex blend, dried, and then
vulcanized in a hot air oven at temperatures of from about 120 C to about 155
C. After
vulcanization, the glove was stripped from the former so that the coated
surface was on
the inside of the glove. The glove was then turned inside-out so that the
coated surface
was on the outside of the glove, and was post-processed by chlorination. The
chlorination consisted of prewashing the glove with water before chlorination
in an
aqueous chlorine solution containing about 300 ppm available chlorine,
neutralizing any
excess chlorine with sodium hydroxide solution, followed by further washing
with water
(this step was carried out several times). The glove was then partially dried
and then
manually inverted again and dried further.
(00073] For good donning with wet or damp hands, the gloves were
transferred to
a tumbling washer for a further lubrication process following the chlorination
step. This
lubrication process included tumbling the gloves with an aqueous solution
comprising
about 1.0% cetylpyridium chloride, 1.0% silicone emulsion, and 1.5% ammonium
salts
of alkyl phosphates. The glove was removed from the tumbler washer, partially
dried,
and manually inverted. The glove was then dried further. The treated glove
could be
easily donned by dry or damp hands.
-22-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
[00074] The properties of the coated powder-free gloves of Formulations B
and C
are set forth in Tables 5 and 6.
Table 5 ¨ Physical Properties of Coated Powder-Free Polychloroprene Gloves
Formulation B
Properties Unaged *Aged
Maturation = 'I day
Tensile Strength, MPa 24.0 27.6
Tensile Stress @300%, MPa 1.47 1.76
Tensile Stress @ 500%, MPa 2.25 2.84
Ultimate Elongation, % 1002 924
Maturation = 3 days
Tensile Strength, MPa 23.8 27.2
Tensile Stress @ 300%, MPa 1.37 1.76
Tensile Stress @500%, MPa 2.16 2.94
Ultimate Elongation, % 1111 865
Maturation = 5 days
Tensile Strength, MPa 22.5 24.5
Tensile Stress @300%, MPa 1.27 1.27
Tensile Stress @ 500%, MPa 1.96 2.45
Ultimate Elongation, % 1120 884
* Aging conditions were 7 days at 70 C
-23-

CA 02802956 2012-12-14
WO 2011/163662 PCT/US2011/042028
Table 6¨ Physical Properties of Coated Powder-Free Polychloroprene Gloves
Formulation C
Properties Unaged *Aged
Maturation = 2 days
Tensile Strength, MPa 17.8 19.2
Tensile Stress @ 300%, MPa 0.98 1.37
Tensile Stress @ 500%, MPa 1.37 2.06
Ultimate Elongation, % 1120 924
Maturation = 3 days
Tensile Strength, MPa 21.6 21.4
Tensile Stress @ 300%, MPa 1.28 1.47
Tensile Stress @ 500%, MPa 1.86 2.84
Ultimate Elongation, % 963 924
* Aging conditions were 7 days at 70 C
[00075] It was seen that the coated powder-free gloves of Formulation B had
good
physical properties both before aging and after accelerated aging for 7 days
at 70 C.
The tensile strength values for the unaged gloves of Formulation B made from
latex that
was matured for 1, 3, or 5 days were all greater than 22 MPa, and after
accelerated
aging, the tensile strength values were all greater than 24 MPa. These values
exceeded the ASTM requirements for polychloroprene examination gloves and
surgical
gloves made from synthetic latex.
[00076] The tensile strength values for the unaged coated powder-free
gloves of
Formulation C made from latex that was matured for 2 or 3 days were
approximately the
same as the commercial powder free gloves of Example 1. Therefore, the results
of
shown in Tables 5 and 6 demonstrate that the vulcanization composition can be
varied
to yield gloves that can meet ASTM requirements for surgical gloves and
examination
gloves.
-24-

Example 4¨ Preparation of powder-free gloves
[00077] Powder-free coated polychloroprene gloves were prepared as
described
above in Example 3, with the exception that the latex blend used for coating
comprised
about 2.5% compounded polychloroprene latex, about 2.5% synthetic polyisoprene

latex, and about 95% water.
[00078] The properties of the resulting gloves were similar to those of
the gloves
prepared in Example 3.
Example 5 ¨ Residual DIXP
[00079] Powdered polychloroprene gloves and powder-free polychloroprene
gloves were prepared using Formulation B as described in Example 2 and Example
3
(but without the lubrication process). The gloves were tested for residual
DIXP using
UV spectroscopy. The gloves were extracted with hexane as well as acetonitrile
and UV
spectra of the extracts were obtained. The UV spectra of both the extracts
showed that
there was no residual DIXP remaining in either of the powdered or powder-free
gloves.
The UV spectroscopy testing method has detection limit of 1 ppm.
[00080] It will, of course, be appreciated that the above description has
been given
by way of example only and that modifications in detail may be made within the
scope
of the present invention.
[00081]
[00082] The invention is capable of considerable modification, alteration,
and
equivalents in form and function, as will occur to those ordinarily skilled in
the pertinent
arts having the benefit of this disclosure.
[00083] While the present invention has been described for what are
presently
considered the preferred embodiments, the invention is not so limited. The
scope of the
claims should not be limited by the preferred embodiments set forth in the
examples, but
should be given the broadest interpretation consistent with the description as
a whole.
-25-
CA 2802956 2017-08-17

Representative Drawing

Sorry, the representative drawing for patent document number 2802956 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2018-07-10
(86) PCT Filing Date 2011-06-27
(87) PCT Publication Date 2011-12-29
(85) National Entry 2012-12-14
Examination Requested 2016-04-05
(45) Issued 2018-07-10

Abandonment History

There is no abandonment history.

Maintenance Fee

Last Payment of $263.14 was received on 2023-06-23


 Upcoming maintenance fee amounts

Description Date Amount
Next Payment if small entity fee 2024-06-27 $125.00
Next Payment if standard fee 2024-06-27 $347.00

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $400.00 2012-12-14
Maintenance Fee - Application - New Act 2 2013-06-27 $100.00 2013-06-06
Maintenance Fee - Application - New Act 3 2014-06-27 $100.00 2014-06-02
Maintenance Fee - Application - New Act 4 2015-06-29 $100.00 2015-06-03
Request for Examination $800.00 2016-04-05
Maintenance Fee - Application - New Act 5 2016-06-27 $200.00 2016-06-03
Maintenance Fee - Application - New Act 6 2017-06-27 $200.00 2017-06-01
Final Fee $300.00 2018-05-22
Maintenance Fee - Application - New Act 7 2018-06-27 $200.00 2018-06-04
Maintenance Fee - Patent - New Act 8 2019-06-27 $200.00 2019-06-21
Maintenance Fee - Patent - New Act 9 2020-06-29 $200.00 2020-06-19
Maintenance Fee - Patent - New Act 10 2021-06-28 $255.00 2021-06-18
Maintenance Fee - Patent - New Act 11 2022-06-27 $254.49 2022-06-17
Maintenance Fee - Patent - New Act 12 2023-06-27 $263.14 2023-06-23
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ALLEGIANCE CORPORATION
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2012-12-14 1 60
Claims 2012-12-14 8 224
Description 2012-12-14 25 1,878
Cover Page 2013-02-11 1 36
Amendment 2017-08-17 20 735
Abstract 2017-08-17 1 21
Claims 2017-08-17 7 199
Description 2017-08-17 27 1,686
Abstract 2017-11-27 1 21
Final Fee 2018-05-22 1 43
Cover Page 2018-06-12 1 39
PCT 2012-12-14 15 563
Assignment 2012-12-14 3 92
PCT 2012-12-17 7 312
Request for Examination 2016-04-05 1 44
Examiner Requisition 2017-02-17 4 256